FINCK BARBARA K

CIK 00012421163 companiesDALLAS, TX

SEC Profile

Transactions

Companies

Filings

CIK

0001242116

Recent Transactions

43 trades

Disposition to Issuer
Forte Biosciences, Inc.$FBRX
Restricted Stock Units
2026-08-27−18,353→ 0 total
Disposition to Issuer
Forte Biosciences, Inc.$FBRX
Stock Option (right to buy)
2026-08-27−2,000→ 0 total
Disposition to Issuer
Forte Biosciences, Inc.$FBRX
Stock Option (right to buy)]
2026-08-27−166→ 0 total
Disposition to Issuer
Forte Biosciences, Inc.$FBRX
Stock Option (right to buy)
2026-08-27−1,000→ 0 total
Disposition to Issuer
Forte Biosciences, Inc.$FBRX
Stock Option (right to buy)
2026-08-27−1,000→ 0 total
Disposition to Issuer
Forte Biosciences, Inc.$FBRX
Stock Option (right to buy)
2026-08-27−7,000→ 0 total
Disposition to Issuer
Forte Biosciences, Inc.$FBRX
Stock Option (right to buy)
2026-08-27−31,000→ 0 total
Award
Forte Biosciences, Inc.$FBRX
Stock Option (right to buy)
2025-03-19+31,000→ 31,000 total
Award
Forte Biosciences, Inc.$FBRX
Stock Option (right to buy)
2024-08-20+50,000→ 50,000 total
Award
Forte Biosciences, Inc.$FBRX
Stock Option (right to buy)
2024-03-21+175,000→ 175,000 total
Award
Forte Biosciences, Inc.$FBRX
Stock Option (right to buy)
2023-09-19+25,000→ 25,000 total
Award
Comera Life Sciences Holdings, Inc.
Common Stock
2023-01-04$1.23/sh+6,756→ 23,033 total
Purchase
Comera Life Sciences Holdings, Inc.
Warrant (Right to Buy)
2023-01-04$0.25/sh+6,756→ 6,756 total
Purchase
Comera Life Sciences Holdings, Inc.
Common Stock
2023-01-04$1.23/sh+6,756→ 23,033 total
Award
Comera Life Sciences Holdings, Inc.
Warrants (right to buy)
2023-01-04$0.25/sh+6,756→ 6,756 total
Award
Forte Biosciences, Inc.$FBRX
Stock Option (right to buy)
2022-06-01+25,000→ 25,000 total
Award
Comera Life Sciences Holdings, Inc.
Stock Option (Right to Buy)
2022-05-19+37,111→ 37,111 total
Award
Forte Biosciences, Inc.$FBRX
Stock Option (right to buy)
2022-03-16+4,166→ 4,166 total
Award
Forte Biosciences, Inc.$FBRX
Stock Option (right to buy)
2022-03-16+50,000→ 50,000 total
Sale
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2018-09-10$18.58/sh−1,760→ 37,043 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Stock Option (right to buy)
2018-09-10−1,760→ 82,941 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2018-09-10$1.42/sh+1,760→ 38,803 total
Sale
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2018-08-13$19.02/sh−1,760→ 37,043 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2018-08-13$1.42/sh+1,760→ 38,803 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Stock Option (right to buy)
2018-08-13−1,760→ 84,701 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2018-07-10$1.42/sh+1,260→ 38,303 total
Sale
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2018-07-10$15.00/sh−1,260→ 37,043 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Stock Option (right to buy)
2018-07-10−1,260→ 86,461 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2018-07-09$1.42/sh+500→ 37,543 total
Sale
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2018-07-09$15.03/sh−500→ 37,043 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Stock Option (right to buy)
2018-07-09−500→ 87,721 total
Sale
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2018-06-18$15.00/sh−1,760→ 37,043 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Stock Option (right to buy)
2018-06-18−1,760→ 88,221 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2018-06-18$1.42/sh+1,760→ 38,803 total
Award
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2018-02-01+130,000→ 130,000 total
Award
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2017-12-15+7,545→ 34,336 total
Award
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2017-08-06+67,000→ 67,000 total
Award
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2016-05-11+78,472→ 78,472 total
Award
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2015-04-01+100,000→ 100,000 total
Conversion
Coherus Oncology, Inc.$CHRS
Series C Preferred Stock
2014-11-12−5,286→ 0 total
Conversion
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2014-11-12+21,505→ 21,505 total
Conversion
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2014-11-12+5,286→ 26,791 total
Conversion
Coherus Oncology, Inc.$CHRS
Series B Preferred Stock
2014-11-12−21,505→ 0 total

Companies

Recent Filings

Address

C/O FORTE BIOSCIENCES, INC. 3060 PEGASUS PARK DR., BUILDING 6

DALLAS, TX, 75247

View on SEC.gov